ask="2.30"
ask_size="3000"
average_daily_volume="1489700"
bid="1.80"
bid_size="100"
book_value="1.31"
change="-0.04"
change_from_200_day_moving_average="-2.01"
change_from_50_day_moving_average="0.18"
change_from_52_week_high="-6.04"
change_From_52_week_low="0.98"
change_in_percent="-1.80%"
close="2.18"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.17"
ebitda="-77.46M"
eps_estimate_current_year="-0.49"
eps_estimate_next_quarter="-0.10"
eps_estimate_next_year="-0.56"
ex_dividend_date="N/A"
float_shares="63466000"
high="2.25"
high_52_weeks="8.22"
last_trade_date="3/6/2017"
last_trade_price="2.18"
last_trade_size="14836"
last_trade_time="4:00pm"
low="2.14"
low_52_weeks="1.20"
market_capitalization="162.56M"
moving_average_200_day="4.19"
moving_average_50_day="2.00"
name="Arrowhead Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="1.80"
open="2.20"
pe_ratio="N/A"
peg_ratio="-0.63"
percent_change_from_200_day_moving_average="-47.95%"
percent_change_from_50_day_moving_average="+8.95%"
percent_change_from_52_week_high="-73.48%"
percent_change_from_52_week_low="+81.67%"
previous_close="2.22"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.69"
price_per_sales="36.95"
revenue="4.48M"
shares_outstanding="74569000"
short_ratio="12.52"
stock_exchange="NMS"
symbol="ARWR"
volume="430856"
weeks_range_52="1.20 - 8.22"
